River & Mercantile Asset Management LLP trimmed its position in shares of Israel Chemicals Ltd (NYSE:ICL) by 28.9% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 845,028 shares of the basic materials company’s stock after selling 342,704 shares during the period. River & Mercantile Asset Management LLP’s holdings in Israel Chemicals were worth $5,100,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in ICL. Lourd Capital LLC purchased a new stake in shares of Israel Chemicals during the third quarter valued at about $167,000. Citadel Advisors LLC purchased a new position in shares of Israel Chemicals in the 3rd quarter valued at approximately $174,000. AXA purchased a new position in shares of Israel Chemicals in the 3rd quarter valued at approximately $181,000. Janus Henderson Group PLC purchased a new position in shares of Israel Chemicals in the 3rd quarter valued at approximately $201,000. Finally, Eqis Capital Management Inc. purchased a new position in shares of Israel Chemicals in the 2nd quarter valued at approximately $245,000. 9.19% of the stock is owned by institutional investors and hedge funds.
Several equities analysts recently commented on the stock. Zacks Investment Research lowered shares of Israel Chemicals from a “hold” rating to a “sell” rating in a research report on Thursday, October 18th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $6.57 price objective on shares of Israel Chemicals in a research report on Sunday, October 21st. BMO Capital Markets reaffirmed a “hold” rating and issued a $5.25 price objective on shares of Israel Chemicals in a research report on Wednesday, September 19th. Finally, ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research report on Friday, August 24th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $5.69.
Israel Chemicals (NYSE:ICL) last announced its quarterly earnings data on Thursday, November 1st. The basic materials company reported $0.10 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.09 by $0.01. The firm had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.38 billion. Israel Chemicals had a net margin of 23.84% and a return on equity of 13.67%. Israel Chemicals’s revenue was down 4.8% on a year-over-year basis. During the same period last year, the firm posted $0.09 EPS. Analysts expect that Israel Chemicals Ltd will post 0.37 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 19th. Investors of record on Tuesday, December 4th will be given a $0.051 dividend. This is a positive change from Israel Chemicals’s previous quarterly dividend of $0.04. This represents a $0.20 annualized dividend and a dividend yield of 3.64%. The ex-dividend date of this dividend is Monday, December 3rd. Israel Chemicals’s dividend payout ratio (DPR) is presently 16.13%.
Israel Chemicals Profile
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Featured Article: Float
Want to see what other hedge funds are holding ICL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Israel Chemicals Ltd (NYSE:ICL).
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.